Latest News About Who Is Ken Griffin

Here’s a concise update on Ken Griffin, based on recent public reporting.

• Who he is: Ken Griffin is the founder and CEO of Citadel, a major hedge fund firm, and a prominent art collector and philanthropist. He is frequently in the news for portfolio moves, philanthropy, and high-profile real estate activity.

• Latest news highlights (late 2024 to early 2026):

  • Portfolio moves: Reports in late 2024 highlighted Griffin selling a large portion of Palantir stake and increasing exposure to Summit Therapeutics, as described in analyses of Citadel’s 13F filings. These moves were framed as shifting from AI-focused plays toward biotech opportunities.
  • Philanthropy and institutions: Griffin has been active philanthropically, including a notable $10 million gift to Northwestern Medicine’s esophageal center, marking a named center in Chicago. This underscores his ongoing involvement in healthcare philanthropy.
  • Arts donations: Griffin donated about $10 million to Pérez Art Museum Miami (PAMM) around November 2024, with the gift supporting exhibitions and programs and featuring a named gallery.
  • Real estate activity: Coverage in late 2024 noted Griffin selling his Chicago penthouse at a sizable loss as part of his retreat from Chicago’s luxury market, illustrating a broader pattern of real estate shifting.

• Context and interpretation:

  • Griffin’s moves are widely interpreted as a strategic tilt toward sectors with long-term growth potential (biotech) after significant gains in AI-related equities earlier in the decade.
  • His philanthropy and museum/health initiatives reinforce his public profile as a major donor in both healthcare and the arts.

If you’d like, I can pull specific articles or compile a short timeline with links to the exact sources for each of these items. I can also summarize any one of these topics in more detail (e.g., the Palantir/Summit position, or the Northwestern Medicine gift).